Veracyte
VCYT
318 hedge funds and large institutions have $3.25B invested in Veracyte in 2024 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 105 increasing their positions, 120 reducing their positions, and 25 closing their positions.
1,042% more call options, than puts
Call options by funds: $8.4M | Put options by funds: $736K
116% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 25
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
17% more capital invested
Capital invested by funds: $2.78B → $3.25B (+$467M)
9% more funds holding
Funds holding: 293 → 318 (+25)
0.61% less ownership
Funds ownership: 106.52% → 105.91% (-0.61%)
13% less repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 120
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$76.4M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$59.7M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$32.1M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$31.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$65.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$32.4M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$27.6M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$27.1M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$23.5M |
VCYT Hedge Fund Activity: Q4 2024 in Review
318 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2024, worth a combined $3.25B — up 17% from $2.78B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new VCYT positions and 25 closed out — a net gain of 29 holders — while 105 added to existing stakes and 120 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $76.4M. The largest seller was Champlain Investment Partners, cutting an estimated $65.5M.
- 318 institutional investors held Veracyte (VCYT) as of Q4 2024, up from 293 in Q3 2024.
- Funds reported $3.25B of Veracyte stock for Q4 2024, up 17% quarter-over-quarter.
- 54 funds opened new Veracyte positions in Q4 2024 and 25 closed out, a net change of +29 holders.
- The largest Veracyte buyer in Q4 2024 was Fidelity Investments, an estimated $76.4M added.
- The largest Veracyte seller in Q4 2024 was Champlain Investment Partners, an estimated $65.5M sold.
Based on aggregated 13F filings for Q4 2024.